Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v26-FR Version v19-EN
Language French English
Date Updated 2018-07-05 2018-04-21
Drug Identification Number 02383551 02383551
Brand name MYLAN-VALSARTAN MYLAN-VALSARTAN
Common or Proper name VALSARTAN VALSARTAN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients VALSARTAN VALSARTAN
Strength(s) 320MG 320MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-07-03 2018-04-20
Actual start date 2018-07-03
Estimated end date Unknown Unknown
Actual end date 2018-07-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments discontinued in ID 20217
Health Canada comments